Dr. Elena Prokopyeva | Immunology and Microbiology | Life Sciences Innovation Award
Senior Researcher of Novosibirsk state university, Russia.
Elena Prokopyeva is a distinguished researcher and educator based at the Federal Research Center of Fundamental and Translational Medicine in Novosibirsk, Russia. Her academic journey began at Novosibirsk State University and progressed through advanced research positions at institutions like the FBRI State Research Center of Virology and Biotechnology ‘Vector’. Dr. Prokopyeva holds a PhD focused on the phenotypic and genotypic properties of influenza viruses and has made significant contributions to virology, studying various viruses including influenza, coronaviruses, and adenoviruses. Her expertise extends to virological methods, immunohistochemistry, and serological diagnostics. Dr. Prokopyeva has authored numerous high-impact publications, reflecting her extensive research in infectious diseases and cell biology. She is also a reviewer for MDPI and an expert for the Russian Science Foundation. Her achievements, coupled with her teaching roles in embryology and histology, underscore her valuable contributions to the scientific community.
Elena Prokopyeva completed her undergraduate studies at Novosibirsk State University (NSU) from 2003 to 2009, where she specialized in Natural Science with a focus on Physiology. She pursued her graduate studies at the Institute of Molecular Biology and Biophysics, Siberian Branch of the Russian Academy of Medical Sciences, from 2009 to 2010, earning expertise in Biochemistry. Her research career began in earnest at the FBRI State Research Center of Virology and Biotechnology ‘Vector’, where she was a Researcher Graduate student from 2010 to 2013, focusing on Virology and Cell Biology. Prokopyeva earned her PhD in December 2015 from the same center, with a thesis on the phenotypic and genotypic properties of pandemic influenza A(H1N1)pdm09 virus. She has continued her academic and research activities at the Federal Research Center of Fundamental and Translational Medicine since 2013.
Elena Prokopyeva has a distinguished career in virology and molecular biology, marked by extensive research and teaching roles. She began her academic journey at Novosibirsk State University, where she pursued undergraduate studies in natural science and later advanced her education with a PhD at the State Research Center of Virology and Biotechnology ‘Vector’. Her professional experience includes significant roles as a researcher at the Federal Research Center of Fundamental and Translational Medicine (FRC FTM) and as a lecturer in “Embryology,” “General Histology,” and “Special Histology” at Novosibirsk State University. Prokopyeva’s expertise spans virological methods, immunofluorescence, and serological diagnostics, with a focus on infectious diseases and cell biology. She has also contributed as a reviewer for MDPI and an expert for the Russian Science Foundation, reflecting her influence in the scientific community.
Elena Prokopyeva’s research primarily focuses on virology, particularly the study of influenza and other respiratory viruses. Her work explores the phenotypic and genotypic properties of pandemic influenza strains and their adaptation in various animal models. Prokopyeva has conducted significant research on the genetic diversity of adenoviruses and the impact of SARS-CoV-2 on respiratory infections in children. Her expertise extends to the characterization of avian and human respiratory viruses, including their interaction with host cells and susceptibility to antiviral treatments. Additionally, Prokopyeva investigates the molecular mechanisms underlying viral pathogenesis and employs advanced techniques such as immunofluorescence, real-time PCR, and electron microscopy to enhance the understanding of infectious diseases. Her contributions aim to improve diagnostic methods and therapeutic strategies for viral infections, reflecting her commitment to advancing the field of virology and infectious disease research.
Elena Prokopyeva possesses a diverse and advanced skill set in research, particularly within virology and infectious diseases. Her expertise includes virological methods such as virus isolation, infection assays, and the determination of virus susceptibility to inhibitors. She is adept in immunofluorescence and immunohistochemistry techniques, essential for studying viral interactions and pathogenesis. Prokopyeva’s proficiency extends to serological diagnostics using hemagglutination and microneutralization assays, as well as molecular techniques like RNA/DNA isolation, real-time PCR, and gel electrophoresis. Her experience with light and electron microscopy further enhances her capability to analyze viral structures and disease mechanisms. Prokopyeva’s role as a reviewer and expert for scientific foundations highlights her strong analytical skills and contributions to advancing the field of virology. Her comprehensive research skills, combined with her active participation in professional organizations, underscore her significant impact and ongoing commitment to her field.
Elena Prokopyeva has earned notable recognition for her research in virology and infectious diseases. Her contributions to the field are highlighted by her role as a reviewer for the MDPI and an expert for the Russian Science Foundation, reflecting her expertise and impact on scientific research. Her work has been published in prestigious journals such as Viruses, Biochemistry (Moscow), and the Journal of Infection in Developing Countries, with high citation rates in Web of Science and Scopus. Prokopyeva’s research on influenza viruses and other pathogens has garnered significant attention, underscoring her expertise in studying viral genetic diversity and pathogenic mechanisms. Additionally, her involvement with the Euro-Asian Society for Infectious Diseases marks her as a key figure in advancing knowledge in her field. These accolades affirm her standing as a distinguished researcher and contribute to her recognition for the Best Researcher Award.
Elena Prokopyeva is a strong candidate for the Best Researcher Award due to her extensive research expertise, impressive publication record, and significant contributions to the field of virology. Her work in understanding and combating viral diseases, coupled with her role in educating future scientists, underscores her value as a researcher. Addressing the areas for improvement could further enhance her standing and impact in the scientific community. Overall, Prokopyeva’s achievements and ongoing contributions make her a worthy candidate for the award.
Publications Top Notes
- “Genetic Diversity of the Human Adenovirus C Isolated from Hospitalized Children in Russia (2019–2022)”
- Authors: Kurskaya, O.G., Prokopyeva, E.A., Dubovitskiy, N.A., Shestopalov, A.M., Sharshov, K.A.
- Journal: Viruses
- Year: 2024
- Volume: 16(3)
- Article Number: 386
- Citations: 1
- “Constitutive Androstane Receptor Agonist Initiates Metabolic Activity Required for Hepatocyte Proliferation”
- Authors: Mazin, M.E., Perevalova, A.M., Yarushkin, A.A., Gulyaeva, L.F., Pustylnyak, V.O.
- Journal: Biochemistry (Moscow)
- Year: 2023
- Volume: 88(8)
- Pages: 1061–1069
- “Changes in the Etiology of Acute Respiratory Infections among Children in Novosibirsk, Russia, between 2019 and 2022: The Impact of the SARS-CoV-2 Virus”
- Authors: Kurskaya, O.G., Prokopyeva, E.A., Sobolev, I.A., Shestopalov, A.M., Sharshov, K.A.
- Journal: Viruses
- Year: 2023
- Volume: 15(4)
- Article Number: 934
- Citations: 8
- “Virological and Genetic Characterization of the Unusual Avian Influenza H14Nx Viruses in the Northern Asia”
- Authors: Dubovitskiy, N., Derko, A., Sobolev, I., Shestopalov, A., Sharshov, K.
- Journal: Viruses
- Year: 2023
- Volume: 15(3)
- Article Number: 734
- Citations: 1
- “Virological and genetic characteristics of human respiratory syncytial viruses isolated in Russia, 2017-2018”
- Authors: Prokopyeva, E.A., Kurskaya, O.G., Solomatina, M.V., Shestopalov, A.M., Sharshov, K.A.
- Journal: Journal of Infection in Developing Countries
- Year: 2023
- Volume: 17(2)
- Pages: 251–259
- Citations: 2
- “Promotion of NR1I3-mediated liver growth is accompanied by STAT3 activation”
- Authors: Mazin, M.E., Yarushkin, A.A., Pustylnyak, Y.A., Prokopyeva, E.A., Pustylnyak, V.O.
- Journal: Molecular Biology Reports
- Year: 2022
- Volume: 49(5)
- Pages: 4089–4093
- Citations: 2
- “Low incidence of human coronavirus among hospitalized children in Novosibirsk city, Russia during pre-pandemic period (2013–2020)”
- Authors: Kurskaya, O.G., Prokopyeva, E.A., Anoshina, A.V., Shestopalov, A.M., Sharshov, K.A.
- Journal: Journal of Microbiology, Immunology and Infection
- Year: 2022
- Volume: 55(2)
- Pages: 336–340
- Citations: 3
- “Anti-Influenza Activity of Medicinal Material Extracts from Qinghai–Tibet Plateau”
- Authors: Kurskaya, O., Prokopyeva, E., Bi, H., Wei, L., Sharshov, K.
- Journal: Viruses
- Year: 2022
- Volume: 14(2)
- Article Number: 360
- Citations: 7
- “Etiology of influenza-like illnesses in the population of Novosibirsk City in the 2018-2019 epidemic season”
- Authors: Kurskaya, O.G., Anoshina, A.V., Leonova, N.V., Shestopalov, A.M., Sharshov, K.A.
- Journal: Russian Journal of Infection and Immunity
- Year: 2021
- Volume: 11(4)
- Pages: 723–736
- Citations: 2
- “Activation of the Akt pathway by a constitutive androstane receptor agonist results in β-catenin activation”
- Authors: Yarushkin, A.A., Mazin, M.E., Pustylnyak, Y.A., Prokopyeva, E.A., Pustylnyak, V.O.
- Journal: European Journal of Pharmacology
- Year: 2020
- Volume: 879
- Article Number: 173135
- Citations: 6